Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)

Midas B. Mulder*, Erwin Birnie, Caroline van Dijck-van Boetzelaer, Gert-Jan van de Geijn, Egbert Boeve, Elsbeth M. Westerman, Paul Hamberg

*Corresponding author voor dit werk

OnderzoeksoutputAcademicpeer review

105 Downloads (Pure)

Zoekresultaten